Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pavel Zák

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Acta Medica (Hradec Kralove)|December 18, 2003
Intravascular large B-cell lymphoma presenting as cutaneous panniculitisKarel Dĕdic, David Belada, Pavel Zák, et al.
Klinicka Mikrobiologie a Infekcni Lekarstvi|September 3, 2010
[Human metapneumovirus]Eva Stepánová, Pavel Zák, Vlasta Stepánová, et al.
Haematologica|October 5, 2006
Plasma levels of basic fibroblast growth factor and vascular endothelial growth factor and their association with IgVH mutation status in patients with B-cell chronic lymphocytic leukemiaLukás Smolej, Ctirad Andrys, Sona Peková, et al.
Vnitrni Lekarstvi|July 2, 2014
[Lymphomatoid granulomatosis - the past and present]Alice Sýkorová, Vít Campr, Petra Kašparová, et al.
Molecular Diagnosis & Therapy|October 30, 2007
Quantitation of minimal residual disease in patients with chronic lymphocytic leukemia using locked nucleic acid-modified, fluorescently labeled hybridization probes and real-time PCR technologySona Peková, Ludmila Bezdícková, Lukás Smolej, et al.
Acta Medica (Hradec Kralove)|November 27, 2007
Addition of rituximab significantly improves outcomes in patients with diffuse large B-cell lymphoma--a single-center, retrospective studyDavid Belada, Lukás Smolej, Monika Hrudková, et al.
Acta Medica (Hradec Kralove)|August 6, 2013
Fifteen years of single center experience with stem cell transplantation for multiple myeloma: a retrospective analysisJakub Radocha, Vladimír Maisnar, Alzbeta Zavrelová, et al.
Bone Marrow Transplantation|July 7, 2023
Survival advantage of treosulfan plus fludarabine (FT14) compared to busulfan plus fludarabine (FB4) in active acute myeloid leukemia post allogeneic transplantation: an analysis from the European Society for Blood and Marrow Transplantation (EBMT) Acute Leukemia Working Party (ALWP)Eleni Gavriilaki, Ioanna Sakellari, Myriam Labopin, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Acta Medica (Hradec Kralove)|December 18, 2003
Intravascular large B-cell lymphoma presenting as cutaneous panniculitisKarel Dĕdic, David Belada, Pavel Zák, et al.
Klinicka Mikrobiologie a Infekcni Lekarstvi|September 3, 2010
[Human metapneumovirus]Eva Stepánová, Pavel Zák, Vlasta Stepánová, et al.
Haematologica|October 5, 2006
Plasma levels of basic fibroblast growth factor and vascular endothelial growth factor and their association with IgVH mutation status in patients with B-cell chronic lymphocytic leukemiaLukás Smolej, Ctirad Andrys, Sona Peková, et al.
Vnitrni Lekarstvi|July 2, 2014
[Lymphomatoid granulomatosis - the past and present]Alice Sýkorová, Vít Campr, Petra Kašparová, et al.
Molecular Diagnosis & Therapy|October 30, 2007
Quantitation of minimal residual disease in patients with chronic lymphocytic leukemia using locked nucleic acid-modified, fluorescently labeled hybridization probes and real-time PCR technologySona Peková, Ludmila Bezdícková, Lukás Smolej, et al.
Acta Medica (Hradec Kralove)|November 27, 2007
Addition of rituximab significantly improves outcomes in patients with diffuse large B-cell lymphoma--a single-center, retrospective studyDavid Belada, Lukás Smolej, Monika Hrudková, et al.
Acta Medica (Hradec Kralove)|August 6, 2013
Fifteen years of single center experience with stem cell transplantation for multiple myeloma: a retrospective analysisJakub Radocha, Vladimír Maisnar, Alzbeta Zavrelová, et al.
Bone Marrow Transplantation|July 7, 2023
Survival advantage of treosulfan plus fludarabine (FT14) compared to busulfan plus fludarabine (FB4) in active acute myeloid leukemia post allogeneic transplantation: an analysis from the European Society for Blood and Marrow Transplantation (EBMT) Acute Leukemia Working Party (ALWP)Eleni Gavriilaki, Ioanna Sakellari, Myriam Labopin, et al.
Pageof 1